Direkt zum Inhalt
Merck

N-acetylglucosamine enhances survival ability of tilapias infected by Streptococcus iniae.

Fish & shellfish immunology (2014-08-15)
Zhi-xue Cheng, Yan-mei Ma, Hui Li, Xuan-xian Peng
ZUSAMMENFASSUNG

Streptococcus iniae infection has emerged as a serious fish health and economic problem in the global aquaculture operations. Current antibiotic options are few and possess severe practical limitations and potential adverse environmental impacts. The major factor contributing to the large burden of S. iniae disease in aquaculture is the lack of fundamental knowledge of innate immunity against the pathogen. In the present study, we use a tilapia model to explore which metabolites are crucial for the defense against the infection caused by S. iniae. We establish GC/MS based metabolic profile of tilapia liver and then compare the metabolic difference between survivals and the dying fish post the bacterial infection. We identify elevating N-acetylglucosamine in survival group as the most crucial metabolite differentiating the survivals from the dying in these fish infected by S. iniae. Exogenous N-acetylglucosamine significantly elevates survival ability of tilapia against the infection caused by S. iniae. Our findings highlight the importance of metabolic strategy against bacterial infections.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Pyridin, ACS reagent, ≥99.0%
Sigma-Aldrich
Pyridin, suitable for HPLC, ≥99.9%
Sigma-Aldrich
O-Methylhydroxylamin -hydrochlorid, 98%
Sigma-Aldrich
Adonitol, ≥99%
Sigma-Aldrich
Pyridin, ≥99%
Sigma-Aldrich
Pyridin, biotech. grade, ≥99.9%
Sigma-Aldrich
Adonitol, BioXtra, ≥99.0% (HPLC)
Supelco
Pyridin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Pyridin, analytical standard